Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Adamis Pharmaceuticals Corp Company Profile (NASDAQ:ADMP)

Consensus Ratings for Adamis Pharmaceuticals Corp (NASDAQ:ADMP) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $15.00 (233.33% upside)

Analysts' Ratings History for Adamis Pharmaceuticals Corp (NASDAQ:ADMP)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/24/2014CRT CapitalReiterated RatingPositive$15.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2014CRT CapitalInitiated CoverageBuy$15.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/31/2012 forward)
Discuss Adamis Pharmaceuticals Corp